Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
نویسندگان
چکیده
The Alzheimer's Disease Neuroimaging Initiative (ADNI) Private Partner Scientific Board (PPSB) is comprised of representatives of private, for-profit entities (including pharmaceutical, biotechnology, diagnostics, imaging companies, and imaging contract research organizations), and nonprofit organizations that provide financial and scientific support to ADNI through the Foundation for the National Institutes of Health. The PPSB serves as an independent, open, and precompetitive forum in which all private sector and not-for-profit partners in ADNI can collaborate, share information, and offer scientific and private-sector perspectives and expertise on issues relating to the ADNI project. In this article, we review and highlight the role, activities, and contributions of the PPSB within the ADNI project, and provide a perspective on remaining unmet needs and future directions.
منابع مشابه
Detection of Alzheimer\\\\\\\'s Disease using Multitracer Positron Emission Tomography Imaging
Alzheimer's disease is characterized by impaired glucose metabolism and demonstration of amyloid plaques. Individual positron emission tomography tracers may reveal specific signs of pathology that is not readily apparent on inspection of another one. Combination of multitracer positron emission tomography imaging yields promising results. In this paper, 57 Alzheimer's disease neuroimaging ini...
متن کاملAlzheimer's disease public-private partnerships: A landscape of the global nonprofit community.
With the prevalence of dementia expected to exceed 115 million worldwide by 2050 [1], stakeholders across all sectors of society recognize the need for an aggressive, coordinated, and global response. Similar challenges have been faced in the past and provide models for how to mount an effective response today. In the mid-1950s and early 1960s, patient advocacy organizations, pharmaceutical com...
متن کاملQ & A: The Alzheimer's disease neuroimaging initiative
What is the Alzheimer’s Disease Neuroimaging Initiative and who funds it? The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a large, highly collaborative longitudinal cohort study aiming to elucidate biomarker trajectories in Alzheimer’s disease (AD). ADNI was initially funded in 2004, based on the urgent need to understand potential biomarkers better in order to facilitate drug develop...
متن کاملThe role of genetics in alzheimer’s disease
Alzheimer's disease is a progressive neurological disorder that causes the brain to shrink (atrophy) and brain cells die. Alzheimer's disease is the most common cause of dementia and causes a decrease in thinking skills and social behaviors. Alzheimer's disease is more common in people over 65 years old. The risk of developing Alzheimer's disease and other types of dementia increases with age,...
متن کاملThe Association of Cognitive Endophenotypes and Risky Single Nucleotide Polymorphisms of Alzheimer's Disease within the <em>Alzheimer's Disease Neuroimaging Initiative (ADNI)</em> Database
The Association of Cognitive Endophenotypes and Risky Single Nucleotide Polymorphisms of Alzheimer's Disease within the Alzheimer's Disease Neuroimaging Initiative (ADNI) Database" (2015). Graduate Theses and Dissertations. Florida for their mentorship and support, both personally and financially, through the completion of my master's degree. Specifically, I would like to thank the Chair of my ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Alzheimer's & dementia : the journal of the Alzheimer's Association
دوره 11 7 شماره
صفحات -
تاریخ انتشار 2015